Top Drug Development Stories


Comment & Analysis »

GlobalData Healthcare

Strong safety and efficacy data position Aerie Pharmaceuticals to submit glaucoma NDA for Roclatan

Aerie Pharmaceuticals’ recently announced safety and efficacy results from the Mercury 1 and Mercury 2 Phase III trials for Roclatan (netarsudil/latanoprost ophthalmic solution) place it in...

Strong safety and efficacy data position Aerie Pharmaceuticals to submit glaucoma NDA for Roclatan
GBI Research

NICE: too nice for too long?

NICE: too nice for too long?
GlobalData Healthcare

Will lampalizumab finally provide a treatment for macular degeneration?

Will lampalizumab finally provide a treatment for macular degeneration?
Chris Lo

PhRMA: resetting the conversation

PhRMA: resetting the conversation
GlobalData Healthcare

Gilead looks to maintain dominance in HIV with its novel STR

Gilead looks to maintain dominance in HIV with its novel STR

Company Releases »

Materials Characterisation Analytical Instruments and Services

Micromeritics
Materials Characterisation Analytical Instruments and Services

Addressing Serialisation Challenges to Achieve Business Benefits and Best Practice Deployment in the Pharmaceutical Sector

Zenith Technologies
Addressing Serialisation Challenges to Achieve Business Benefits and Best Practice Deployment in the Pharmaceutical Sector

Fume Hoods, Process Stations, and Wet Scrubber Systems for Pollution Control

Salare Fume Hoods, Process Stations, and Wet Scrubber Systems for Pollution Control

Crystallisation and Filtration Brochure

SYSTAG, System Technik AG
Crystallisation and Filtration Brochure

B&W Tek NanoRam Handheld Raman Spectrometer

B&W Tek B&W Tek NanoRam Handheld Raman Spectrometer

Drug Development Insights »

Companies »